hs impact hs impact

IMPACT

Patient portrayal

The impact of HS
goes deeper
than
the skin

Patients with hidradenitis suppurativa (HS) may deal with debilitating physical and
emotional burdens.1,2 The chronic, systemic, and often progressive nature of the
condition may lead to distress, which can impact many aspects of a patient's
life, including their career and intimate relationships.1-4 For some patients,
helping alleviate the psychosocial burdens of HS is their top priority.5

Patients can have an alarmingly poor quality of life

Acute or chronic skin pain is one of the features of HS. Pain often occurs in sensitive anatomical regions, which can impact a patient's ability to perform even the most basic activities of daily living, including walking, sitting, sleeping, using the bathroom, and getting dressed.6-8 Timely referrals to specialists for pain management and mental healthcare may help mitigate these burdens.

You can help patients with the physical and psychological burdens of HS6

1665646713

1_lyb6cj6a

The healthcare providers featured in these videos were compensated for their time. These videos represent their opinions and do not represent the opinions of Novartis.

The burdens
associated with
HS may exacerbate
each other

  • Recurrent or persistent HS can lead to the formation of more lesions and more distress9
  • Shame, embarrassment, and impaired sexual health may lead to depression and anxiety3,10
  • The embarrassment of HS means patients are less likely to discuss HS with a
    physician, leading to diagnostic delays7

Patient portrayal

  • Pain ~97% of patients with HS experience pain4,11
  • Odor 88% of patients with HS experience malodorous discharge12
  • Depression ~43% of patients with HS experience depression4,13
  • Suicide Over 2x the risk of completed suicide in patients with HS vs those with psoriasis4
  • Mental Health Deterioration ~81% of patients have persistent psychological symptoms or limitations from HS skin damage14
  • Negative Career ImpactUp to 25% of patients with HS may be unemployed4
  • Sexual Health Deterioration Up to 62% of women experience sexual impairments15
    Up to 52% of men experience erectile dysfunction15
  • IsolationPatients with HS experience high levels of loneliness which correlate with impaired quality of life16,17

The impacts of HS are not limited only to those listed.

Patient portrayal

Resources for you and
your patients

These tools are specially designed to assist you and your patients in understanding and managing HS.

Explore resources

Illuminate the facts about hidradenitis suppurativa

The following questions can serve as helpful reminders about HS. Swipe or click on the correct answers.

What occurs at higher rates in those with HS than in the general population?18

next arrow

Acute asthma due to systemic manifestations

SO CLOSE. Keep going

NEXT
next arrow

Chronic kidney disease

SO CLOSE. Keep going

NEXT
next arrow

Depression and anxiety

CORRECT. Keep it up

NEXT

Since HS is a physical condition with an emotional impact, what is important for patients during appointments?19

next arrow

A deeper understanding of HS by the healthcare provider

CORRECT.

NEXT
next arrow

Compassion and empathy

SO CLOSE. Keep going

NEXT
next arrow

Meaningful discussions around comorbidities

SO CLOSE. Keep going

NEXT
next arrow

All of the above

CORRECT. Keep it up

NEXT

Some of the most common locations of HS lesions are6:

next arrow

The dermis of sun-exposed areas of the body

SO CLOSE. Keep going

NEXT
next arrow

Cheeks, hands, toes, and knees

SO CLOSE. Keep going

NEXT
next arrow

Axillae, groin, and inner thighs

CORRECT. Keep it up

NEXT

SO CLOSE

You answered out of questions correctly.

Try again or learn more to help bring HS out of the shadows.

GOOD JOB

You answered out of questions correctly.

Clinical Deep Dive

Learn how to identify and diagnose
HS early to
shed light on improved
outcomes

Get Involved

Share your commitment and
raise awareness about HS today

References: 1. Alikhan A et al. J Am Acad Dermatol. 2019;81(1):76-90. 2. Sabat R et al. Nat Rev Dis Primers. 2020;6(1):18. 3. Alavi A et al. Int J Womens Dermatol. 2018;4(2):74-79. 4. Goldburg SR et al. J Am Acad Dermatol. 2020;82(5):1045-1058. 5. Shih T et al. Int J Womens Dermatol. 2022;8(3):e040. 6. Kimball AB et al, eds. Hidradenitis Suppurativa: A Disease Primer. Adis; 2017. 7. Shah M et al. J Clin Cosmet Dermatol. 2020;4(2):1-4. 8. Garg A et al. J Am Acad Dermatol. 2020;82(2):366-376. 9. Fletcher JM et al. Clin Exper Immunol. 2020;201(2):121-134. 10. Tzellos T et al. Dermatol Ther (Heidelb). 2020;10(1):63-71. 11. Matusiak Ł et al. Acta Derm Venereol. 2018;98(2):191-194. 12. Alavi A et al. J Cutan Med Surg. 2017;21(6):513-524. 13. Vazquez BG et al. J Invest Dermatol. 2013;133(1):97-103. 14. Kirby JS. J Am Acad Dermatol. 2016;74(6):1269-1270. 15. Janse IC et al. Br J Dermatol. 2017;176:1042-1047. 16. Fisher S et al. Arch Dermatol Res. 2020;312(6):421-426. 17. Kouris A et al. Dermatology. 2016;232(6):687-691. 18. Phan K et al. Ann Transl Med. 2020;8(13):821. 19. Collier EK et al. Int J Dermatol. 2020;59(6):744-747.

9/23   262710-1